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Chylopericardium usually occurs secondary to trauma, cardiothoracic surgery, radiation therapy, or neoplasm of the
mediastinum. Idiopathic chylopericardium is extremely rare. We report a case of primary chylopericardium in a
79-year-old male patient. Although pericardial window and thoracic duct ligation are the treatment of choice, the
patient has been doing well for six months since video-assisted thoracoscopic pericardial window.
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Chylopericardium is a rare and benign disease entity in
which chylous fluid accumulates in the pericardial cavity.
Chylopericardium developed secondary to iatrogenic
after cardiac surgery, trauma, or malignant tumors, in-
cluding mediastinal tumors. However, primary idiopathic
chylopericardium is rarely reported [1,2].Case presentation
A 79-year-old male was admitted for the management of
pericardial effusion. He denied a history of trauma, infec-
tion, radiation, mediastinal neoplasm, or cardiothoracic
surgery and had a history of adenocarcinoma in the
rectum 1 year earlier. The rectal cancer was treated with
colonoscopic polyp removal. Pericardial effusion was
incidentally found in an abdominal computed tomography
(CT) during the evaluation of rectal cancer (Figure 1).
Echocardiography showed pericardial effusion (maximum
10 mm depth on diastolic phase) without cardiac tampon-
ade physiology, and an ejection fraction was 70%. Despite
medical treatment for 1 year, pericardial effusion was still
noted in follow-up echocardiography. He was referred to
our department for further evaluation and treatment for
pericardial effusion.
Chest x-ray showed an enlarged cardiac shadow. The
patient was asymptomatic, his vital signs were stable,
and his body temperature was normal. Laboratory
findings did not show any signs of inflammation (white
blood cell count of 3900/L, erythrocyte sedimentation* Correspondence: drcs5223@daum.net
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reproduction in any medium, provided the orrate of 3 mm/hr, high sensitivity C-reactive protein con-
centration of 0.15 mg/dl).
The patient elected to undergo video-assisted
thoracoscopic pericardial window for the evaluation and
management of pericardial effusion. At the time of the
operation, we thought that tuberculosis was the most
probable diagnosis. The patient was placed in right down
decubitus position. 10.5 mm port was inserted into the
5th intercostals space midaxillary line and another two
5.5 mm ports were inserted into one inch ahead of the
4th and 6th intercostals space anterior axillary line. The
pericardium was grasped and a pericardial window was
created. On opening the pericardium, a yellowish, turbid
fluid was extracted (Figure 2). Pericardial fluid examin-
ation revealed triglyceride 478 mg/dl, total cholesterol
158 mg/dl, and lymphocytes 98%.
Cytologic examination of the pericardial fluid revealed a
lymphocyte-dominant cell count (98%) and no evidence
of malignant cells. Bacterial cultures were negative, and
tuberculosis was excluded. Pathologic examination of the
pericardium demonstrated no evidence of malignancy or
tuberculosis. A chest CT scan taken after pericardial win-
dow did not reveal mediastinal neoplasm, mediastinal
lymphadenopathy or other abnormalities that might have
obstructed the thoracic duct.
The patient started a normal diet on a routine sched-
ule. Despite the normal diet after operation, the drain-
age decreased to below 100 ml per day on the day after
operation. Although we considered a lymphangiogram,
it was not available in our hospital, and the chylous
effusion was discontinued. The chest tube was removed
on the 5th operative day. Thoracic duct ligation was
considered, but the patient did not desire furthertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Preoperative computed tomography scan revealed
pericardial effusion.
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The patient was followed up 6 months after operation
without recurrence of pericardial effusion.
Discussion
Chylopericardium is a rare cause of pericardial effusion.
It sually occurs secondary to trauma, cardiothoracic sur-
gery, radiation therapy, or neoplasm of the mediastinum
[3]. Primary idiopathic chylopericardium is extremelyFigure 2 Pericardial fluid, showing a turbid and
yellowish appearance.rare; recent case reports identified the lymphatic leak
and communication with the pericardial sac, which was
visualized by lymphangiography, combined lymphangi-
ography and CT, or intraoperative thoracic ductogram
[1,2]. While the exact pathophysiology of primary
chylopericardium has not been established, the reflux of
chylous fluid into the pericardial space has been
suggested as an etiology [4]. Damage to the thoracic
duct valves and the communication of the thoracic duct
to the pericardial lymphatics or abnomally elevated
pressure in the thoracic duct could cause chylous fluid
reflux.
Chylous fluid is characterized by a milky yellowish
appearance, triglycerides >500 mg/dL, a cholesterol/
triglyceride ratio < 1.0, a lymphocyte dominant fluid cell
count, and negative fluid cultures [3].
Clinical manifestations may vary from asymptomatic,
as in our case, to signs of cardiac tamponade. The most
common symptoms are dyspnea and fatigue, and chest
pain and cough can also be present. While most patients
are asymptomatic, conservative treatment is associated
with a high recurrence rate (60%) [4] and may lead to
pericarditis or cardiac tamponade; therefore, surgical
intervention should be considered.
Pericardial effusion is usually diagnosed by chest x-ray,
echocardiography or chest CT. Although chylopericardium
may be diagnosed by noninvasive imaging using 99 mTc,
labeled RBC and the oral administration of 131I-triolein
[5], the nature of the effusion is revealed by pericardio-
centesis or pericardial window. When the diagnosis of
chylopericardium has been established, exclusion of
history of trauma and thoracic surgery, chest CT to
investigate a secondary cause of chylopericardium is
needed. If no other cause of chylopericardium can be
found, primary idiopathic chylopericardium is diagnosed.
Conventional lymphangiography or CT combined with
lymphangiography may reveal abnormalities of the
thoracic duct and in some cases demonstrates the
presence of communications between the pericardial sac
and the lymphatic system [1,6].
Although various management options, including diet
therapy with medium-chain triglycerides, pericardiocen-
tesis, pericardial window, and ligation of the thoracic
duct have been suggested, the optimal treatment of
chylopericardium is unclear. Conservative treatment of
idiopathic chylopericardium is usually not satisfactory
and a failure rate of 57-60% has been reported [3,4].
Surgical treatment should be considered, even in asymp-
tomatic patients, to avoid subsequent progression to car-
diac tamponade or constrictive pericarditis. According
to a review by Akamatsu et al [4], the most commonly
used surgical method is ligation and resection of the
thoracic duct with establishment of pericardial window
(41 patients, 52%), pericardial window alone (21 patients,
Kwon et al. Journal of Cardiothoracic Surgery 2013, 8:28 Page 3 of 3
http://www.cardiothoracicsurgery.org/content/8/1/2827%), and ligation and resection of the thoracic duct
(7 patients, 9%).
The reaccumulation of chylous fluid in the pericardial
space after operation is a major concern following surgi-
cal treatment. Thoracic duct ligation and pericardial
window are the most effective procedures to prevent
recurrence. Pericardial window alone is simple but car-
ries a high incidence of recurrence [2-4] because it does
not close the communication between thoracic duct and
pericardial sac. Therefore, careful follow up is required,
and thoracic duct ligation should be performed if
chylopericardium recurs.
Although thoracic duct ligation was not performed in
this case, our patient did not show any reaccumulation
of chylous pericardial effusion after pericardial window.
We assumed that the longstanding chylopericardium
and balanced pressure between the pericardial space and
thoracic duct eliminated the communication such that
the patient remained asymptomatic.Conclusion
Although chylopericardium is an uncommon cause of
pericardial effusion, clinicians should keep in mind the
possibility of chylous effusion. VATS pericardial window is
a safe and effective alternative treatment option, although
it is associated with a risk of recurrence. In case of
reaccumulation, surgical ligation of the thoracic duct
should be considered.Consent
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